PDCD1 and myeloid sarcoma: Subtype analysis revealed increased numbers of pro-inflammatory PD-1+ Th1, Th17, Tc1 and Tc17 T cell subsets in MS patients compared to controls, while the number of PD-1+ Treg cells was reduced.